Dachaigh › Cirrhosis bileach a' gheòla
Sgrùdaidhean clionaigeach Cirrhosis bileach a' gheòla a’ fastadh anns na SA
Tha 8 sgrùdaidhean airson Cirrhosis bileach a' gheòla a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
Le stàit
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06016842Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07424677Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06051617Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
A’ fastadhÌre 1
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06825559Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy
A’ fastadhSgrùdadh amharc
Gach aois · Banairean · Air ùrachadh 31 Lùna 2026 · NCT07556913Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT07216235Biobank for Cholestatic Liver Diseases.
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 17 Gearr 2026 · NCT03445585Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 29 Cèit 2025 · NCT01793168Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.